We are live on ! Find out more
MD icon

Pediatrix Medical

229 hedge funds and large institutions have $1.08B invested in Pediatrix Medical in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 80 increasing their positions, 74 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,161% more call options, than puts

Call options by funds: $701K | Put options by funds: $31K

59% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 22

8% more capital invested

Capital invested by funds: $995M → $1.08B (+$84.6M)

5% more funds holding

Funds holding: 218229 (+11)

8% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 74

4.29% less ownership

Funds ownership: 100.11%95.82% (-4.3%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
229
Holders Change
+11
Holders Change %
+5.05%
% of All Funds
3.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
35
Increased
80
Reduced
74
Closed
22
Calls
$701K
Puts
$31K
Net Calls
+$670K
Net Calls Change
+$328K
Name Holding Trade Value Shares
Change
Change in
Stake
ACB
26
Aristotle Capital Boston
Massachusetts
$8.62M -$868K -62,904 -9%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$8.24M -$544K -39,413 -6%
Principal Financial Group
28
Principal Financial Group
Iowa
$7.24M +$529K +38,306 +7%
BCM
29
Bridgeway Capital Management
Texas
$7.16M +$188K +13,607 +3%
Citadel Advisors
30
Citadel Advisors
Florida
$6.96M -$7.58M -549,031 -51%
N
31
Nuveen
North Carolina
$6.37M +$3.52M +255,273 +111%
OAM
32
Oberweis Asset Management
Illinois
$6.12M +$6.44M +466,600 New
AQR Capital Management
33
AQR Capital Management
Connecticut
$5.83M -$5.03M -364,257 -45%
TI
34
Trexquant Investment
Connecticut
$5.66M +$3.15M +227,825 +112%
CM
35
CastleKnight Management
New York
$5.58M -$3.21M -232,221 -35%
Bank of America
36
Bank of America
North Carolina
$4.43M -$2M -144,861 -30%
PAM
37
Panagora Asset Management
Massachusetts
$3.98M +$501K +36,265 +14%
Nomura Holdings
38
Nomura Holdings
Japan
$3.88M +$4.09M +295,919 New
CEI
39
Clark Estates Inc
New York
$3.71M -$473K -34,260 -11%
EF
40
Empowered Funds
Pennsylvania
$3.68M +$188K +13,607 +5%
Nordea Investment Management
41
Nordea Investment Management
Sweden
$3.5M +$1.24M +89,739 +52%
Ameriprise
42
Ameriprise
Minnesota
$3.47M -$997K -72,243 -21%
UBS AM
43
UBS AM
Illinois
$3.36M +$257K +18,627 +8%
Jane Street
44
Jane Street
New York
$3.18M -$838K -60,681 -20%
Legal & General Group
45
Legal & General Group
United Kingdom
$3.13M +$156K +11,272 +5%
Raymond James Financial
46
Raymond James Financial
Florida
$3.07M +$3.23M +233,657 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$2.95M +$52.8K +3,822 +2%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$2.8M -$165K -11,944 -5%
Public Sector Pension Investment Board (PSP Investments)
49
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.76M +$432K +31,272 +17%
RA
50
Royce & Associates
New York
$2.7M +$120K +8,711 +4%

MD Hedge Fund Activity: Q4 2024 in Review

229 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q4 2024, worth a combined $1.08B — up 8.5% from $995M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new MD positions and 22 closed out — a net gain of 13 holders — while 80 added to existing stakes and 74 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $40M. The largest seller was Rubric Capital Management (New York), cutting an estimated $70.8M.

  • 229 institutional investors held Pediatrix Medical (MD) as of Q4 2024, up from 218 in Q3 2024.
  • Funds reported $1.08B of Pediatrix Medical stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 35 funds opened new Pediatrix Medical positions in Q4 2024 and 22 closed out, a net change of +13 holders.
  • The largest Pediatrix Medical buyer in Q4 2024 was Fidelity Investments, an estimated $40M added.
  • The largest Pediatrix Medical seller in Q4 2024 was Rubric Capital Management (New York), an estimated $70.8M sold.

Based on aggregated 13F filings for Q4 2024.